🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer laws, risking fines, prosecution or prison.

Platform Response and Material Elimination

According to the social media company, the platform has removed violative material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Online Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.

After minutes of joining one group, a seller shared contact information, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, posts show black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious medical dangers”.